Our transthoracic biopsy practices accompanied by the imaging process: The contribution of positron emission tomography usage to accurate diagnosis

Basit Öğe Kaydı
dc.contributor.authorIntepe, Yavuz Selim
dc.contributor.authorMetin, Bayram
dc.contributor.authorSahin, Sevinc
dc.contributor.authorKaya, Bugra
dc.contributor.authorOkur, Aylin
dc.date.accessioned2024-02-23T14:20:43Z
dc.date.available2024-02-23T14:20:43Z
dc.date.issued2016
dc.departmentNEÜen_US
dc.description.abstractObjectives: The objective of this study was to compare the results of transthoracic biopsies performed through the use of FDG PET/CT imaging with the results of transthoracic needle biopsy performed without using the FDG PET/CT imaging.Methods: The medical files of a total of 58 patients with pulmonary and mediastinal masses. A total of 20 patients, who were suspected of malignancy with the SUVmax value of over 2.5 in FDG PET/CT, underwent a biopsy process. Twelve patients with no suspicion of malignancy in accordance with CT images and with the SUVmax value below 2.5 underwent no biopsy procedure, and hence, they were excluded from the study. On the other hand, 26 patients directly went through a biopsy process with the suspicion of malignancy according to CT imaging, regardless of performing any FDG PET/CT imaging.Results: According to the biopsy results, the number of the patients diagnosed with cancer was 20 (43.5%), while the number of non-cancerous patients was 26 (56.5%). When these findings were considered, it was determined that the sensitivity of the whole TTNB (transthoracic needle biopsy) was 80.8%, and the specificity was found as 100%. The positive predictive value of the whole TTNB was 100%, while its negative predictive value was found to be 80%. The sensitivity in TTNB performed together with FDG PET/CT was 90.9%, whereas the specificity was 100%. The positive predictive value of TTNB with FDG PET/CT was 100%, while its negative predictive value was found to be 81.8%. The sensitivity in TTNB performed without the use of FDG PET/CT was 73.3%, whereas the specificity was determined as 100%.Conclusions: Performing FDG PET/CT imaging process prior to a transthoracic biopsy as well as preferring FDG PET/CT for the spot on which the biopsy will be performed during the transthoracic biopsy procedure increases the rate of receiving accurate diagnosis.en_US
dc.identifier.doi10.1080/17843286.2016.1155810
dc.identifier.endpage220en_US
dc.identifier.issn1784-3286
dc.identifier.issn2295-3337
dc.identifier.issue4en_US
dc.identifier.pmid27142092en_US
dc.identifier.scopus2-s2.0-84976260705en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage214en_US
dc.identifier.urihttps://doi.org/10.1080/17843286.2016.1155810
dc.identifier.urihttps://hdl.handle.net/20.500.12452/13258
dc.identifier.volume71en_US
dc.identifier.wosWOS:000380152400003en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherTaylor & Francis Ltden_US
dc.relation.ispartofActa Clinica Belgicaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectTransthoracic Biopsyen_US
dc.subjectPet Cten_US
dc.subjectTomographyen_US
dc.subjectThoracic Massen_US
dc.titleOur transthoracic biopsy practices accompanied by the imaging process: The contribution of positron emission tomography usage to accurate diagnosisen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu